Squamous cell lung cancer: from tumor genomics to cancer therapeutics
about
Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so farEGFR: The Paradigm of an Oncogene-Driven Lung CancerSmall cell lung cancer: will recent progress lead to improved outcomes?Lung cancer in the era of precision medicineCorrelation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients wHistorical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer.Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials.Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin In East Asian Patients with Stage IV Squamous Non-Small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIREEpidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma.Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer.BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinomaCombination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancer
P2860
Q26745776-A215979F-3398-4DEC-ADD3-EE371CB3C7A8Q35619241-D1E895DF-85B0-42B2-A796-8AA106184AE7Q35836257-023182C1-B859-499E-AB8C-31E7B176670AQ35861107-E2864B2B-4581-449B-A34C-CC79B0919A40Q37123936-8F0362DC-CC14-453C-A744-5341323170FBQ37598057-5CCB2402-84BD-4CA6-8843-FCBD078F1D45Q37699414-716540F7-693B-4C41-850A-A6186F4A8487Q38549559-74A9E9B0-1ED5-4297-81E5-98FE024E58D1Q38748140-ABFA812F-0D6D-4707-8C49-BEDEED5A5A83Q39006417-33B1953A-55B6-4D12-AF62-C010D334A41EQ39254692-5B5B0E36-8035-474F-9824-2629C21BF0E2Q40343596-F39AC6B0-2B04-4880-8BF5-BD16BE536BC2Q47102677-94415E8E-5FFA-4DF2-A2D4-9796A643B1D7Q47129993-173A640D-C0A3-40F6-97CC-909F2F24F06AQ47839818-FA953EC3-6739-4120-BE9D-8A1A10816C2AQ48231139-4585E9A7-5E7F-497D-A092-052B1265346CQ49418567-370387C8-B134-4027-A7E2-114B076A5167Q51704583-DB21EA98-D9C1-43E2-9F58-8C608051731DQ54964718-1EDF3DAC-51E9-40A1-93A5-1D94DE84A9CAQ58737274-14A945E9-FFB1-4030-9287-7DDD09B4FCAFQ58770914-EEF3B81B-81BF-48B4-A134-3DF997CDB00C
P2860
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@ast
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@en
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@nl
type
label
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@ast
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@en
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@nl
prefLabel
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@ast
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@en
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@nl
P2093
P2860
P3181
P1476
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
@en
P2093
D. R. Gandara
F. R. Hirsch
P. N. Lara
P. S. Hammerman
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-14-3039
P407
P577
2015-05-15T00:00:00Z